Home Page
Back to Home Page »
Contents
Dr Darina O’Flanagan retires from HPSC
Zika virus infection update
Updated protocol for enhanced surveillance of bloodstream infections reported to EARS-Net in Ireland
Hand hygiene compliance: Call for latest national acute hospital audit data
Yellow Fever Outbreak - Africa
Increase in reporting of pertussis in infants
Stay well when swimming this summer
Antimicrobial consumption in public acute hospitals, 2015
Latest HPSC reports
Editorial Board

Dr L Kyne, RCPI (Paed)
Prof C Bradley, ICGP
Dr N O'Sullivan, ISCM
Mr E O'Kelly, NVRL
Dr P McKeown, HPSC
Dr L Thornton, FPHMI
Prof C Bergin, IDSI
M Kelly, HPSC
(Editor)

Health Protection Surveillance Centre

25-27 Middle Gardiner St
Dublin 1

Tel: +353 (0) 1 8765300
Fax: +353 (0) 1 8561299
info@hpsc.ie
www.hpsc.ie

Contents of Epi Insight should not be reproduced without permission.

© HPSC, 2016. All rights reserved

Subscribe

Enter your email address in the box below to receive an email each time we post a new issue of our newsletter.


Increase in reporting of pertussis in infants

The Health Protection Surveillance Centre wishes to alert the public and clinicians of an increase of pertussis notifications in infants (babies < 12 months) for the first 20 weeks of 2016. Provisional data for 2016 weeks 1-20 is presented here in this report.

Background

Pertussis is a vaccine preventable disease. The HSE implements a national immunisation programme to provide pertussis vaccine to the Irish population. Since 2012, pregnant women in Ireland have been recommended pertussis vaccine at weeks 27-36 of their pregnancy to protect their babies from pertussis disease in the first months of their baby’s life. An HSE audit of pertussis vaccination during pregnancy in 2013 reported that only 6.4% of postnatal women had received the pertussis vaccine during their pregnancy (unpublished data). At this time in 2016, anecdotal reports suggest that many mothers are still not aware of this recommendation and therefore not availing of the opportunity to provide this protection to their baby.

Summary of pertussis in 2016

For the first 20 weeks of 2016, a total of 51 pertussis notifications (all ages) were made to the national Computerised Infectious Disease Reporting system (CIDR). This compares to 49 cases (all ages) for the same time period in 2015. However, in 2016 an increased proportion of all cases were reported among infants. To date 51% of all pertussis notifications are infant cases (n=26) compared to 25% (n=12) in 2015. (Figure 1)

 

Figure 1. Pertussis notifications in infants (cumulative), for weeks 1-20, 2015 and 2016

Pertussis cases in infants weeks 1-20 2016 (provisional)

Of the 26 infant pertussis notifications reported during this time, 25 cases were reported as confirmed. The median age of cases was 3 months (range 1-8 months). For 19 cases information was available on hospitalisation; 13 of whom were hospitalised. Dates of admission and discharge were provided for seven of those hospitalised; the median length of stay for these infants was 4 days (range 3-15 days). One infant died as a result of pertussis.

Information on vaccination status of the child was available for 25 of the 26 infant cases; 17 were unvaccinated; 6 of these infant cases were not eligible for vaccination as they were < 2 months of age. (Figure 2). (Note: Pertussis vaccination of infants is recommended for all infants (unless contraindicated) at 2, 4, 6 months of age).

 

Figure 2. Pertussis cases (infants) by infant’s vaccination status and age at notification, weeks 1-20 2016 (n=25)

 

Information on maternal antenatal pertussis vaccination was available for 20 of the 26 infant cases. None of the mothers reported receiving pertussis vaccination during their pregnancy. 

Key points

  • During the first 20 weeks of 2016, Ireland has seen an increase in pertussis notifications in infants. There was one infant death reported as a result of this disease.
  • Since 2012, the National Immunisation Advisory Committee of the RCPI (NIAC) has recommended pertussis vaccination of mothers during pregnancy to protect the infant from pertussis disease in the first months of life.
  • Since 2013 pertussis vaccine has been available free of charge for pregnant women from the HSE National Cold Chain Service. All women are required to pay an administration fee. 
  • All health care professionals (GPs, practice nurses, midwives and obstetricians) who provide care and advice to pregnant women are in a unique position to recommend pertussis vaccination to pregnant women and therefore improve protection to infants in the first months of life.
  • Infants should be vaccinated against pertussis according to the national immunisation schedule (2, 4, 6, months of age).

HSE HPSC wishes to raise awareness among pregnant women, and their health care providers of the increase in pertussis, particularly in young infants, so that mothers request pertussis vaccination during the antenatal period (weeks 27-36 ideally) from their primary care provider. Vaccination is the most effective way to prevent pertussis in the infant during the first months of life.


For more information on pertussis vaccination recommendations please click here

Information on whooping cough (pertussis) vaccine for pregnant women is located here

Further information on pertussis is available here          

Newsletter Marketing Powered by Newsweaver